A new assay for quantitative detection of Aspergillus antigen

By EUROIMMUN

Invasive aspergillosis (IA) is a life-threatening mycosis with a high morbidity and mortality rate in immunocompromised patients. A newly developed enzyme-linked immunosorbent assay from EUROIMMUN allows for the quantitative detection of Aspergillus antigen in patient serum or lung fluid samples, supporting early diagnosis of IA. With the option of semi-automated processing, it is especially suitable for high-throughput IA diagnostics in high-risk patients.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.